The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
about
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophreniaDifferential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeatsDopamine transporter genotype predicts implicit sequence learningThe variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter densityNeurogenetics of depression: a focus on reward processing and stress sensitivityThe dopamine transporter gene, a spectrum of most common risky behaviors, and the legal status of the behaviorsMeta-analysis reveals significant association of 3'-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations.Dopamine transporter gene variation modulates activation of striatum in youth with ADHDDopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD.SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.The neurobiology of individual differences in complex behavioral traits.Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish populationGenetic determinants of time perception mediated by the serotonergic system.Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.Neural response to working memory load varies by dopamine transporter genotype in children.Genotype and ancestry modulate brain's DAT availability in healthy humans.A neurogenetic approach to impulsivityMonoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART).Imaging neurochemical endophenotypes: promises and pitfalls.Effect of dopamine transporter genotype on caudate volume in childhood ADHD and controls.A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHDPharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Dopamine genes and attention-deficit hyperactivity disorder: a review.The role of the dopamine transporter (DAT) in the development of PTSD in preschool childrenGenetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.Molecular genetics of schizophrenia: a critical review.Genetically determined dopamine availability predicts disposition for depression.The policy and ethical implications of genetic research on attention deficit hyperactivity disorder.DAT genotype modulates brain and behavioral responses elicited by cigarette cues.Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction.Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.Food reinforcement and eating: a multilevel analysis.Dopamine genes and nicotine dependence in treatment-seeking and community smokers.Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors.Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity.
P2860
Q24302099-DA0406F2-77F6-42B1-8B66-5A101C6D5EEBQ24338948-99383A8D-C6BE-45CF-8BC3-F6A14FCC4472Q24611834-9005CC41-58FD-4044-996E-FBB4B3F515FEQ25255374-270E9304-523B-4730-88A3-5322F9921A02Q26830563-B1BF78EB-87E5-410A-8DE1-205EDF375321Q28472980-F1CD0962-E86B-4B6B-AEBE-89B791A1B91CQ30279060-FC51D4F2-1F4C-420E-B57A-74F5665C10A7Q30495097-25E8FAA9-B460-4399-BB73-912F756772C1Q33344259-9BEDCD40-63C5-4BB5-A0D6-3AD40FBED061Q33404436-E6D0C87D-9C7D-45F0-9C9F-EB80B4B3AD21Q33435975-4731D934-73BD-4DC0-9266-3DEAF237C507Q33504408-8E2471BB-5981-410E-8AE0-040269514958Q33700398-66EEBBB0-5C94-4D75-B83E-45172D3B1108Q33865234-99BAFCF3-29F0-4282-B8ED-4339ADD878A3Q33925631-8D99C80D-B11C-4B60-A11C-8F4CEA98ACAAQ33985968-07507463-6F94-4E3D-A8C4-D595D539445AQ34035619-8845F114-9E8A-4B26-8B93-C1C502F6E71CQ34146169-CD74490D-EF82-4706-93AB-87730E14CEB4Q34314211-CA857DE1-62F0-4B7C-A00A-06E1E2B58CC3Q34355244-CB7D1ADA-67A3-42E8-8F44-F99AFA75FC4CQ34440838-7A51CCC2-F913-465D-B844-F02B1470625DQ34574817-DE64EF7B-2F30-4B8A-991A-D509BC7C104AQ34576427-4CE6FA00-0F45-4883-8BFC-3BD937A06A97Q34660456-8A28B5E0-C90F-4EF5-A69F-9578082BA8A5Q34982551-5530A9BF-4A11-4A6D-BDCB-20CFE258F53AQ35066854-DC29A53A-F4BD-4C4B-B7AB-D4609A4E7040Q35156295-3D4E486C-B5E5-4A16-A481-8EBE3C98E1EAQ35554545-B741D6B1-BA78-4E61-B1B2-D7C7951981AEQ35590435-FB3C44D1-D922-4D24-A682-2EF575572091Q35609346-2E84D22E-33C5-4DFA-A4E4-2D091DDC0355Q35632783-B08BC87C-F02E-4AC7-983F-DFA455629202Q35947872-D6AC1FF2-67B5-4A00-8530-2B41B3F0C3CEQ35990231-5D230BCF-731D-48EF-9215-D997156DE3FBQ36203479-3D8685BC-7108-4730-A920-A37A6028F737Q36416603-4DAC00C4-B3C0-49A4-826A-59759A5F9A5CQ36570998-656AA10E-0B75-47CC-96C7-4496DAE5041EQ36639796-D1AA8F83-F822-40D2-8B21-C0C4BD0E9C3BQ36648476-9184F4B5-E669-4780-827B-1464174C0FD5Q36665045-502142F0-E190-4468-9D4B-5E85B6902610Q37157279-4F5848F8-E4DD-48E7-A242-311A7BAB963B
P2860
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The variable number of tandem ...... ansporter phenotype in humans.
@en
The variable number of tandem ...... ansporter phenotype in humans.
@nl
type
label
The variable number of tandem ...... ansporter phenotype in humans.
@en
The variable number of tandem ...... ansporter phenotype in humans.
@nl
prefLabel
The variable number of tandem ...... ansporter phenotype in humans.
@en
The variable number of tandem ...... ansporter phenotype in humans.
@nl
P2093
P1476
The variable number of tandem ...... ansporter phenotype in humans.
@en
P2093
A Abi-Dargham
C H van Dyck
D Martinez
M Laruelle
P304
P356
10.1016/S0893-133X(00)00216-5
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1018422742